In breast cancer, this phenomenon has been correlated with the presence of estrogen/progesterone receptors, which are well-known modulators of cell signaling pathways involved in cell cycle, angiogenesis, and metastasis but also known to trigger lipogenic pathways, including the FASN signaling [105, 106]. Here, FASN is linked to breast cancer.